Cargando…
Clinical Management of COVID-19 Patients – An Update
SARS-CoV-2 virus may cause COVID-19 disease, which causes mild-to-moderate disease in 80% of laboratory-confirmed cases which may be community-managed. A considerable age-dependent mortality is seen among elderly and other at-risk populations but among young and healthy individuals it is < 0.5%....
Autores principales: | Mølhave, Martin, Agergaard, Jane, Wejse, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206588/ https://www.ncbi.nlm.nih.gov/pubmed/34243904 http://dx.doi.org/10.1053/j.semnuclmed.2021.06.004 |
Ejemplares similares
-
Long-Term Symptoms among Hospitalized COVID-19 Patients 48 Weeks after Discharge—A Prospective Cohort Study
por: Mølhave, Martin, et al.
Publicado: (2021) -
Effect of Vitamin D in Long COVID Patients
por: Hikmet, Ramsen Ghasan, et al.
Publicado: (2023) -
TH-243. Post COVID-19 myopathy
por: Agergaard, Jane, et al.
Publicado: (2022) -
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
por: Preckel, Benedikt, et al.
Publicado: (2020) -
Long‐Term COVID‐19 Smell and Taste Disorders Differ Significantly from Other Post‐Infectious Cases
por: Stankevice, Dovile, et al.
Publicado: (2022)